SELECTA BIOSCIENCES, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 54201
 
  
 
B82Y SPECIFIC USES OR APPLICATIONS OF NANO-STRUCTURES; MEASUREMENT OR ANALYSIS OF NANO-STRUCTURES; MANUFACTURE  OR TREATMENT OF NANO-STRUCTURES1340
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1138
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 5162
 
  
 
C07K PEPTIDES 4132
 
  
 
C08G MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS 3117
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 293
 
  
 
C07D HETEROCYCLIC COMPOUNDS 2160
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2204

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0071,394 POLYESTER POLYMER MATRICES FOR THE DELIVERY OF ALLERGENSAug 24, 17Mar 15, 18[A61K]
2018/0043,023 DOSE SELECTION OF ADJUVANTED SYNTHETIC NANOCARRIERSAug 23, 17Feb 15, 18[A61K]
2017/0349,433 IMMUNONANOTHERAPEUTICS PROVIDING A TH1-BIASED RESPONSEJun 22, 17Dec 07, 17[A61K, B82Y]
2017/0258,927 FORMULATIONS AND DOSES OF PEGYLATED URICASEMar 11, 17Sep 14, 17[A61K]
2016/0256,401 TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO THERAPEUTIC PROTEINSMar 04, 16Sep 08, 16[A61K]
2016/0128,986 METHODS AND COMPOSITIONS RELATED TO THE USE OF LOW HLB SURFACTANTS IN THE PRODUCTION OF SYNTHETIC NANOCARRIERS COMPRISING A RAPALOGNov 05, 15May 12, 16[A61K]
2016/0128,987 METHODS AND COMPOSITIONS RELATED TO SYNTHETIC NANOCARRIERS WITH RAPAMYCIN IN A STABLE, SUPER-SATURATED STATENov 05, 15May 12, 16[A61K]
2016/0074,531 METHODS AND COMPOSITIONS FOR ATTENUATING GENE THERAPY ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSESSep 07, 15Mar 17, 16[A61K, G06Q, C12N]
2016/0074,532 METHODS AND COMPOSITIONS FOR ATTENUATING GENE EDITING ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSESSep 07, 15Mar 17, 16[A61K, G06Q, C12N]
2016/0067,228 METHODS AND COMPOSITIONS FOR ATTENUATING ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSESSep 07, 15Mar 10, 16[A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9884112 Immunomodulatory agent-polymeric compoundsMar 13, 15Feb 06, 18[C08J, A61K, B82Y, C08G, C07D]
9764031 Dose selection of adjuvanted synthetic nanocarriersMay 20, 15Sep 19, 17[A61K]
9295718 Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteinsApr 27, 12Mar 29, 16[A61K, B82Y]
9289476 Tolerogenic synthetic nanocarriers for allergy therapyApr 27, 12Mar 22, 16[A61K, B82Y]
9289477 Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte responsesApr 27, 12Mar 22, 16[A61K, B82Y]
9265815 Tolerogenic synthetic nanocarriersApr 27, 12Feb 23, 16[A61K, B82Y]
9066978 Dose selection of adjuvanted synthetic nanocarriersMay 26, 11Jun 30, 15[A61K]
9006254 Immunomodulatory agent-polymeric compoundsDec 23, 13Apr 14, 15[A61K, A01N, B82Y, C08G]
8652487 Tolerogenic synthetic nanocarriers for inducing regulatory B cellsApr 27, 12Feb 18, 14[A61K, C07K]
8629151 Immunomodulatory agent-polymeric compoundsMay 26, 10Jan 14, 14[A01N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0220,501 TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO THERAPEUTIC PROTEINSAbandonedFeb 03, 15Aug 04, 16[A61K]
2014/0242,173 TARGETED SYNTHETIC NANOCARRIERS WITH PH SENSITIVE RELEASE OF IMMUNOMODULATORY AGENTSAbandonedMay 08, 14Aug 28, 14[A61K]
2013/0058,894 THERAPEUTIC PROTEIN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS AND METHODS OF USEAbandonedApr 27, 12Mar 07, 13[A61K, C12N, A61P]
2013/0058,901 TRANSPLANTABLE GRAFT-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS AND METHODS OF USEAbandonedApr 27, 12Mar 07, 13[A61K, C12N, G01N]
2013/0058,902 DENDRITIC CELL SUBSETS FOR GENERATING INDUCED TOLEROGENIC DENDRITIC CELLS AND RELATED COMPOSITIONS AND METHODSAbandonedApr 27, 12Mar 07, 13[A61K, C12N, A61P]
2013/0058,963 INDUCED TOLEROGENIC DENDRITIC CELLS FOR GENERATING CD8+ REGULATORY T CELLSAbandonedApr 27, 12Mar 07, 13[A61K, C12N, A61P]
2013/0058,970 INDUCED TOLEROGENIC DENDRITIC CELLS TO REDUCE SYSTEMIC INFLAMMATORY CYTOKINESAbandonedApr 27, 12Mar 07, 13[A61K, A61P]
2013/0058,974 ANTIGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS TO REDUCE CYTOTOXIC T LYMPHOCYTE RESPONSESAbandonedApr 27, 12Mar 07, 13[A61K, C12N, A61P]
2013/0058,975 ANTIGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS TO REDUCE ANTIBODY RESPONSESAbandonedApr 27, 12Mar 07, 13[A61K, C12N, A61P]
2013/0058,976 ALLERGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS FOR ALLERGY THERAPYAbandonedApr 27, 12Mar 07, 13[A61K, C12N, A61P]
2013/0058,977 COMPOSITIONS AND METHODS RELATED TO INDUCED TOLEROGENIC DENDRITIC CELLS EXTERNALLY LOADED WITH MHC CLASS I-RESTRICTED EPITOPESAbandonedApr 27, 12Mar 07, 13[A61K, C12N, G01N, A61P]
2013/0058,978 INDUCED TOLEROGENIC DENDRITIC CELLS FOR INDUCING REGULATORY B CELLSAbandonedApr 27, 12Mar 07, 13[A61K, C12N, G01N, A61P]
2013/0059,009 COMPOSITIONS AND METHODS FOR PRODUCING ANTIGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS WITH SYNTHETIC NANOCARRIERSAbandonedApr 27, 12Mar 07, 13[A61K, B82Y, A61P]
2013/0039,954 CONTROL OF ANTIBODY RESPONSES TO SYNTHETIC NANOCARRIERSAbandonedJul 27, 12Feb 14, 13[A61K, B82Y, A61P]
2013/0028,857 SYNTHETIC NANOCARRIERS COMPRISING POLYMERS COMPRISING MULTIPLE IMMUNOMODULATORY AGENTSAbandonedJul 27, 12Jan 31, 13[A61K, C08G, B82Y, B82B, A61P, B32B]
2012/0301,498 CONTROLLED RELEASE OF IMMUNOSUPPRESSANTS FROM SYNTHETIC NANOCARRIERSAbandonedApr 27, 12Nov 29, 12[A61K, A61P]
2012/0301,510 TOLEROGENIC SYNTHETIC NANOCARRIERS COUPLED TO CD1D-RESTRICTED ANTIGENS AND METHODS OF USEAbandonedApr 27, 12Nov 29, 12[A61K, B82Y, A61P]
2012/0276,156 TOLEROGENIC SYNTHETIC NANOCARRIER COMPOSITIONS WITH TRANSPLANTABLE GRAFT ANTIGENS AND METHODS OF USEAbandonedApr 27, 12Nov 01, 12[A61K, B82Y, A61P]
2012/0276,160 TOLEROGENIC SYNTHETIC NANOCARRIERS FOR REGULATING INNATE IMMUNE RESPONSESAbandonedApr 27, 12Nov 01, 12[A61K, B82Y, A61P]
2012/0177,701 COMPOSITIONS COMPRISING IMMUNOSTIMULATORY NUCLEIC ACIDS AND RELATED METHODSAbandonedDec 30, 11Jul 12, 12[A61K, C07H, C12Q, B82Y, C12N, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.